A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media

Journal of Pediatrics

Volumn 143, Issue 3, 2003, Pages 377-385

  Chonmaitree, Tasnee ^a,b   Saeed, Kokab ^a   Uchida, Tatsuo ^a   Heikkinen, Terho ^a   Baldwin, Constance D ^a   Freeman Jr , Daniel H ^a   McCormick, David P ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CEFTRIAXONE; CHLORPHENIRAMINE MALEATE; CORTICOSTEROID; PLACEBO; PREDNISOLONE;

ACUTE DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAPER DERMATITIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR EFFUSION; NERVOUSNESS; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TYMPANOMETRY; URINE VOLUME; XEROSTOMIA;

EID: 0141839063     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00293-2     Document Type: Article

References (50)

1. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-9.
2. Carlin SA, Marchant CD, Shurin PA, Johnson CE, Super DM, Rehmus JM. Host factors and early therapeutic response in acute otitis media. J Pediatr 1991;118:178-83.
3. Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Hiss DM, Leiberman A. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J 1998;17:776-82.
4. Carlin SA, Marchant CD, Shurin PA, Johnson CE, Murdell-Panek D, Barenkamp SJ. Early recurrences of otitis media: reinfection or relapse? J Pediatr 1987;110:20-5.
5. Chonmaitree T, Owen MJ, Patel JA, Hedgpeth D, Horlick D, Howie VM. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr 1992;120:856-62.
6. Shurin PA, Pelton SI, Donner A, Klein JO. Persistence of middle ear effusion after acute otitis media in children. N Engl J Med 1979;300:1121-3.
7. Teele DW, Klein JO, Rosner B, the Greater Boston Otitis Media Study Group: Bratton L, Fisch GR, Mathieu OR, Porter PJ, Starobin SG, Tarlin LD, Younes RP. Burden and practice of pediatrics: middle ear disease during the first five years of life. JAMA 1983;249:1026-9.
8. Teele DW, Klein JO, Rosner B. Epidemlology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989;160:83-94.
9. Chonmaitree T, Owen MJ, Howie VM. Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J Infect Dis 1990;162:546-9.
10. Arola M, Ziegler T, Ruuskanen O. Respiratory virus infection as a cause of prolonged symptoms in acute otitis media. J Pediatr 1990;116:697-701.
11. Chonmaitree T, Patel JA, Lett-Brown MA, Uchida T, Garofalo R, Owen MJ, et al. Virus and bacteria enhance histamine production in middle ear fluids of children with acute odds media. J Infect Dis 1994;169:1265-70.
12. Chonmaitree T, Patel JA, Garofalo R, Uchida T, Sim T, Owen MJ, et al. Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media. Ann Otol Rhinol Laryngol 1996;105:968-74.
13. Dennis RG, Whitmire RN, Jackson RT. Action of inflammatory mediators on middle ear mucosa: a method for measuring permeability and swelling. Arch Otolaryngol 1976;102:420-4.
14. Frady RP, Parker WA, Jackson RT. Studies on permeability of the middle ear mucosa. The feasibility of blocking inflammatory mediators. Arch Otolaryngol 1977;103:47-51.
15. Jung TTK, Park YM, Schlund D, Weeks D, Miller S, Wong O, et al. Effect of prostaglandin, leukotriene, and arachidonic acid on experimental otitis media with effusion in chinchillas. Ann Otol Rhinol Laryngol Suppl 1990;148:28-32.
16. Bierman CW, Simons FER, Simons KJ. Antihistamines. In: Yaffe SJ, Aranda JV, editors. Pediatric pharmacology: therapeutic principles in practice. Philadelphia: WB Saunders; 1992. p. 303-16.
17. Church MK, Gradidge CF. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol 1980;69:663-7.
18. Ting S, Rauls DO, Reiman BEF. Inhibitory effect of hydroxazine on antigen-induced histamine release in vivo. J Allergy Clin Immunol 1985;75:63-6.
19. Theoharides TC, Manolidis SS, Vliagoftis H, Manolidis LS. Treatment of secretory otitis media with local instillation of hydroxyzine. Int Arch Allergy Immunol 1994;103:95-101.
20. Moran DM, Mutchie KD, Higbee MD, Paul LD. The use of antihistamine-decongestant in conjunction wlrh an anti-infective drug in the treatment of acute otitis media. J Pediatr 1982;101:132-6.
21. Stickler GB, Rubenstein MM, McBean JB, Hedgecock LD, Hugstad JA, Griffing T. Treatment of acute otitis media in children, IV: a fourth clinical trial. Am J Dis Child 1967;114:123-30.
22. Bain DJG. Can the clinical course of acute otitis media be modified by systemic decongestant or antihistamine treatment? Br Med J 1983;287:654-6.
23. Bhambhani K, Foulds DM, Swamy KN, Eldis FE,Fischel JE. Acute otitis media in children: are decongestants or antihistamines necessary? Ann Emerg Med 1983;12:13-6.
24. Chilton LA, Skipper BE. Antihistamines and alpha-adrenergic agents in treatment of odds media. South Med J 1979;72:953-5.
25. Lampe RM, Weir MR, McLeod HL, Artelejo L III. A clinical trial of antihistamine, decongestant, or placebo in antibiotic-treated acute otitis media followed with pneumatic otoscopy and impedance tympanomety. Mil Med 1981;146:259-61.
26. Schnore SK, Sangster JF, Gerace TM, Bass MJ. Are antihistamine-decongestants of value in the treatment of acute otitis media in children? J Fam Pract 1986;22:39-43.
27. Hamaguchi Y, Juhn SK, Sakakura Y. Antiinflammatory effects of a corticosteroid and protease inhibitor agents on antigen-induced otits media in chinchillas. Am J Otolaryngol 1988;9:142-8.
28. Schimmer BP, Parker KL. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th edition. New York: McGraw-Hill; 2001. p. 1649-77.
29. Butler CC, van Der Voort JH. Steroids for otitis media with effusion: a systemic review. Arch Pediatr Adolesc Med 2001;155:641-7.
30. Giebink GS, Berman S, Bluestone CD, Canafax DM, Casselbrant ML, Ingvarsson L, et al. Recent advances in odds media: treatment. Panel report of the 6th Research C on Recent Advances in Otitis Media. Ann Otol Rhinol Laryngol 1998;107:67-80.
31. Ruohola A, Heikkinen T, Jero J, Puhakka T, Juven T, Narkio-Makela M, et al. Oral prednisolone is an effective adjuvant therapy for acute otitis media with discharge through rympanostomy tubes. J Pediatr 1999;134:459-63.
32. Hennekens CH. Issues in the design and conduct of clinical trials. J Natl Cancer Inst 1984;73:1473-6.
33. SAS Institute Inc. SAS/STAT User's Guide. Version 8. Cary, NC: SAS Institute; 1999.
34. Elashoff JD. nQuery Advisor Version 4.0 User's Guide, Los Angeles: Calif; 2000.
35. Flynn CA, Griffin G, Tudiver F. Decongestants and antihistamines for acute otitis media in children (Cochrane Review). [Journal Article] Cochrane Database Syst Rev [computer file]. 2001;2:CD001727.
36. McCormick DP, Saeed K, Uchida T, Baldwin CD, Heikkinen T, Lett-Brown MA, et al. Middle ear fluid histamine and leukorriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment. Int J Pediatr Otorhinolaryngol 2003;67:221-30.
37. Juhn SK, Jung TTK, Lin J, Rhee CK. Effects of inflammatory mediators on the middle ear pathology and on inner ear function. Ann N Y Acad Sci 1997;830:130-42.
38. Wanner A, Zarzecki S, Hirsch J, Epstein S. Tracheal mucous transport in experimental canine asthma. J Appl Physiol 1975;39:950-7.
39. Peerless SA, Noiman AH. Etiology of odds media with effusion: antihistamines-decongestants. Laryngoscope 1980;90:1852-64.
40. Jian L, Li Wan Po A. Effect of xylometazoline and antazoline on ciliary beat frequency. Int J Pharmacol 1992;86:59-67.
41. Su XY, Li Wan Po A. The effect of some commercially available antihistamine and decongestant intra-nasal formulations on ciliary beat frequency. J Clin Pharm Ther 1993;18:219-22.
42. Rinaldo A, Fertilo A. The pathology and clinical features of "glue ear": a review. Eur Arch Otorhinolaryngol 2000;257:300-3.
43. Hamaguchi Y, Juhn SK, Sakakura Y. Antiinflammatory effects of a corticosteroid and protease inhibitor agents on antigen-induced otitis media in chinchillas. Am J Otolaryngol 1988;9:142-8.
44. Jung TTK, Giebink GS, Juhn SK. Effects of ibuprofen, corticosteroid, and penicillin on the pathogenesis of experiment Pneumococcal otitis media. In: Proceedings of the Third International Symposium on Recent Advances in Otitis Media with Effusion. (Ft Lauderdale, Fla). Philadelphia: BC Decker; 1984. p. 269-72.
45. Mustafa MM, Ramilo O, Saez-Llorens X, Olsen KD, Magness RR, McCracken GH. Cerebrospinal fluid prostaglandins, interleukln 1β, and tumor necrosis factor in bacterial meningitis. Am J Dis Child 1990;144:883-887.
46. Odio CM, Faingezicht I, Paris M, Nassar M, Baltodano A, Rogers J, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-31.
47. Groneck P, Ruess D, Gotze-Speer B, Speer CP. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 1993;122:938-44.
48. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, et al. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:1430-9.
49. Daly K, Giebink GS, Batalden PB, Anderson RS, Le CT, Lindgren B. Resolution of otitis media with effusion with the use of a stepped treatment regimen of trimethoprim-sulfamethoxazole and prednisone. Pediatr Infect Dis J 1991;10:500-6.
50. Opal SM, Cross AS. Clinical trials for severe sepsis: past failures, and future hopes. Infect Dis Clin North Am 1999;13:285-97.